Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 4/20 | 0.56 |
| ▸ | IDO1 | P14902 | 12/20 | 0.53 |
| ▸ | CYP2C9 | P11712 | 5/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.53 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.53 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.53 |
| ▸ | LMNA | P02545 | 3/20 | 0.53 |
| ▸ | NR1I2 | O75469 | 3/20 | 0.53 |
| ▸ | PGR | P06401 | 3/20 | 0.53 |
| ▸ | ADORA3 | P0DMS8 | 3/20 | 0.53 |
| ▸ | ADRA2B | P18089 | 3/20 | 0.53 |
| ▸ | CHRM3 | P20309 | 3/20 | 0.53 |
| ▸ | CNR1 | P21554 | 3/20 | 0.53 |
| ▸ | SLC6A2 | P23975 | 3/20 | 0.53 |
| ▸ | SLC6A4 | P31645 | 3/20 | 0.53 |
| ▸ | DRD3 | P35462 | 3/20 | 0.53 |
| ▸ | OPRK1 | P41145 | 3/20 | 0.53 |
| ▸ | MC3R | P41968 | 3/20 | 0.53 |
| ▸ | KCNH2 | Q12809 | 3/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Nitric Acid SCHEMBL15346828 | 0.92 | CYP3A4 (0.59) | CYP19A1IDO1CYP2C9CYP3A4CYP1A2 | |
| SCHEMBL11017620 | 0.91 | IDO1 (0.56) | CYP19A1IDO1CYP2C9CYP3A4CYP1A2 | |
| SCHEMBL29370767 | 0.91 | IDO1 (0.56) | CYP19A1IDO1CYP2C9CYP3A4CYP1A2 | |
| SCHEMBL11015944 | 0.91 | IDO1 (0.56) | CYP19A1IDO1CYP2C9CYP3A4CYP1A2 | |
| SCHEMBL18694736 | 0.82 | CYP3A4 (0.55) | CYP19A1IDO1CYP2C9CYP3A4CYP1A2 | |
| SCHEMBL28226515 | 0.78 | CYP19A1 (0.50) | CYP19A1IDO1CYP2C9CYP3A4CYP1A2 | |
| Hydrochloric Acid SCHEMBL11176357 | 0.76 | CYP19A1 (0.58) | CYP19A1IDO1CYP2C9CYP3A4CYP1A2 | |
| SCHEMBL3984360 | 0.76 | CYP19A1 (0.58) | CYP19A1IDO1CYP2C9CYP3A4CYP1A2 | |
| SCHEMBL11270467 | 0.75 | CYP19A1 (0.47) | CYP19A1IDO1CYP2C9CYP3A4CYP1A2 | |
| SCHEMBL11262135 | 0.74 | CYP19A1 (0.43) | CYP19A1IDO1CYP2C9CYP3A4CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090226500-A1 | SUTURES AND ANTI-SCARRING AGENTS | ANGIOTECH PHARMACEUTICALS, INC (CA) | 2009-09-10 | — | — | US | disclosed |
| EP-1978930-A2 | SUTURES AND ANTI-SCARRING AGENTS | Angiotech Pharmaceuticals, Inc. (CA) | 2008-10-15 | — | — | EP | disclosed |
| WO-2007089878-A2 | SUTURES AND ANTI-SCARRING AGENTS | ANGIOTECH PHARMACEUTICALS, INC. (CA) | 2007-08-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090226500-A1 | SUTURES AND ANTI-SCARRING AGENTS | COL1A1, COL2A1, COL14A1 | CYP19A1 4572/4885IDO1 3748/4885CYP2C9 4882/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.